DIFUNCTIONAL ENOLS OF N-PROTECTED AMINO-ACIDS AS LOW-MOLECULAR-WEIGHT AND NOVEL INHIBITORS OF HIV-1 PROTEASE

被引:14
作者
VAILLANCOURT, M
VANASSE, B
COHEN, E
SAUVE, G
机构
[1] UNIV QUEBEC, INST ARMAND FRAPPIER, 531 BOUL PRAIRIES, LAVAL H7N 4Z3, QUEBEC, CANADA
[2] UNIV MONTREAL, DEPT MICROBIOL & IMMUNOL, MONTREAL H3C 3J7, QUEBEC, CANADA
关键词
D O I
10.1016/S0960-894X(00)80308-X
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis of difunctional enols of simple amino acids and their novel inhibitory activity against human immunodeficiency virus type 1 protease (HIV-PR) are described. By modifying the substituents on these enols, we were able to achieve mid-nanomolar range in activity against HIV-1 protease which is, to our knowledge, the best reported activity for molecules that do not contain at least one peptide linkage.
引用
收藏
页码:1169 / 1174
页数:6
相关论文
共 23 条
[1]   SYNTHETIC NON-PEPTIDE INHIBITORS OF HIV PROTEASE [J].
BLUMENSTEIN, JJ ;
COPELAND, TD ;
OROSZLAN, S ;
MICHEJDA, CJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 163 (02) :980-987
[2]   INHIBITION OF HIV-1 PROTEINASE BY NONPEPTIDE CARBOXYLATES [J].
BRINKWORTH, RI ;
WOON, TC ;
FAIRLIE, DP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 176 (01) :241-246
[3]   HIV-1 PROTEASE SPECIFICITY OF PEPTIDE CLEAVAGE IS SUFFICIENT FOR PROCESSING OF GAG AND POL POLYPROTEINS [J].
DARKE, PL ;
NUTT, RF ;
BRADY, SF ;
GARSKY, VM ;
CICCARONE, TM ;
LEU, CT ;
LUMMA, PK ;
FREIDINGER, RM ;
VEBER, DF ;
SIGAL, IS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (01) :297-303
[4]   STRUCTURE-BASED DESIGN OF NONPEPTIDE INHIBITORS SPECIFIC FOR THE HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE [J].
DESJARLAIS, RL ;
SEIBEL, GL ;
KUNTZ, ID ;
FURTH, PS ;
ALVAREZ, JC ;
DEMONTELLANO, PRO ;
DECAMP, DL ;
BABE, LM ;
CRAIK, CS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6644-6648
[5]   DESIGN AND SYNTHESIS OF HIV PROTEASE INHIBITORS - VARIATIONS OF THE CARBOXY TERMINUS OF THE HIV PROTEASE INHIBITOR-L-682,679 [J].
DESOLMS, SJ ;
GIULIANI, EA ;
GUARE, JP ;
VACCA, JP ;
SANDERS, WM ;
GRAHAM, SL ;
WIGGINS, JM ;
DARKE, PL ;
SIGAL, IS ;
ZUGAY, JA ;
EMINI, EA ;
SCHLEIF, WA ;
QUINTERO, JC ;
ANDERSON, PS ;
HUFF, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (09) :2852-2857
[6]   INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE INVITRO - RATIONAL DESIGN OF SUBSTRATE-ANALOG INHIBITORS [J].
DREYER, GB ;
METCALF, BW ;
TOMASZEK, TA ;
CARR, TJ ;
CHANDLER, AC ;
HYLAND, L ;
FAKHOURY, SA ;
MAGAARD, VW ;
MOORE, ML ;
STRICKLER, JE ;
DEBOUCK, C ;
MEEK, TD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :9752-9756
[7]   ROLE OF CAPSID PRECURSOR PROCESSING AND MYRISTOYLATION IN MORPHOGENESIS AND INFECTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
GOTTLINGER, HG ;
SODROSKI, JG ;
HASELTINE, WA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (15) :5781-5785
[8]   DIFFERENT REQUIREMENTS FOR PRODUCTIVE INTERACTION BETWEEN THE ACTIVE-SITE OF HIV-1 PROTEINASE AND SUBSTRATES CONTAINING -HYDROPHOBIC-ASTERISK HYDROPHOBIC- OR -AROMATIC-ASTERISK PRO- CLEAVAGE SITES [J].
GRIFFITHS, JT ;
PHYLIP, LH ;
KONVALINKA, J ;
STROP, P ;
GUSTCHINA, A ;
WLODAWER, A ;
DAVENPORT, RJ ;
BRIGGS, R ;
DUNN, BM ;
KAY, J .
BIOCHEMISTRY, 1992, 31 (22) :5193-5200
[9]   STRUCTURE-BASED, C2 SYMMETRICAL INHIBITORS OF HIV PROTEASE [J].
KEMPF, DJ ;
NORBECK, DW ;
CODACOVI, LM ;
WANG, XC ;
KOHLBRENNER, WE ;
WIDEBURG, NE ;
PAUL, DA ;
KNIGGE, MF ;
VASAVANONDA, S ;
CRAIGKENNARD, A ;
SALDIVAR, A ;
ROSENBROOK, W ;
CLEMENT, JJ ;
PLATTNER, JJ ;
ERICKSON, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (10) :2687-2689
[10]   ACTIVE HUMAN IMMUNODEFICIENCY VIRUS PROTEASE IS REQUIRED FOR VIRAL INFECTIVITY [J].
KOHL, NE ;
EMINI, EA ;
SCHLEIF, WA ;
DAVIS, LJ ;
HEIMBACH, JC ;
DIXON, RAF ;
SCOLNICK, EM ;
SIGAL, IS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4686-4690